Literature DB >> 8397364

Ultrasound in salivary gland disease.

J N Bruneton1, M Y Mourou.   

Abstract

This text reviews the normal ultrasound (US) anatomy of the salivary glands along with tumoral, lithiasic, and inflammatory pathologies. For salivary gland tumors, US does have limitations (failure to visualize the entire parotid gland, relations with the nerve plexus, in-depth spread of large tumors, false-negative errors of malignancy for small encapsulated tumors). However, US is a simple technique allowing correct identification of the benign nature of a lesion in over 80% of the cases. For lesions under 3 cm in diameter, US is generally the only imaging technique used; for larger lesions, CT or MR is required. Sialolithiasis and inflammatory diseases are being documented by US more and more and the indications for sialography have strongly decreased.

Entities:  

Mesh:

Year:  1993        PMID: 8397364     DOI: 10.1159/000276440

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  5 in total

1.  [On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany].

Authors:  S F Preuss; O Guntinas-Lichius
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

2.  Ultrasonographic biometry in normal salivary glands.

Authors:  P Dost
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  CT of submandibular gland sialolithiasis.

Authors:  E Avrahami; M Englender; E Chen; D Shabtay; R Katz; M Harell
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

4.  Comparative study of MR sialography and digital subtraction sialography for benign salivary gland disorders.

Authors:  Marc Kalinowski; Johannes T Heverhagen; Elisabeth Rehberg; Klaus Jochen Klose; Hans-Joachim Wagner
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

5.  [Predictors of malignancy in the management of parotid tumors: about 76 cases].

Authors:  Brahim Bouaity; Youssef Darouassi; Mehdi Chihani; Mohamed Mliha Touati; Haddou Ammar
Journal:  Pan Afr Med J       Date:  2016-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.